Daly Blánaid, Sharif Mohammad O, Newton Tim, Jones Kate, Worthington Helen V
Dental Practice & Policy, King’s College London Dental Institute, London, UK.
Cochrane Database Syst Rev. 2012 Dec 12;12:CD006968. doi: 10.1002/14651858.CD006968.pub2.
Alveolar osteitis (dry socket) is a complication of dental extractions and occurs more commonly in extractions involving mandibular molar teeth. It is associated with severe pain developing 2 to 3 days postoperatively, a socket that may be partially or totally devoid of blood clot and in some patients there may be a complaint of halitosis. It can result in an increase in postoperative visits.
To assess the effects of local interventions for the prevention and treatment of alveolar osteitis (dry socket) following tooth extraction.
The following electronic databases were searched: the Cochrane Oral Health Group Trials Register (to 29 October 2012), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 10), MEDLINE via OVID (1946 to 29 October 2012) and EMBASE via OVID (1980 to 29 October 2012). There were no restrictions regarding language or date of publication. We also searched the reference lists of articles and contacted experts and organisations to identify any further studies.
We included randomised controlled trials of adults over 18 years of age who were having permanent teeth extracted or who had developed dry socket post-extraction. We included studies with any type of local intervention used for the prevention or treatment of dry socket, compared to a different local intervention, placebo or no treatment. We excluded studies reporting on systemic use of antibiotics or the use of surgical techniques for the management of dry socket because these interventions are evaluated in separate Cochrane reviews.
Two review authors independently undertook risk of bias assessment and data extraction in duplicate for included studies using pre-designed proformas. Any reports of adverse events were recorded and summarised into a table when these were available. We contacted trial authors for further details where these were unclear. We followed The Cochrane Collaboration statistical guidelines and reported dichotomous outcomes as risk ratios (RR) and calculated 95% confidence intervals (CI) using random-effects models. For some of the split-mouth studies with sparse data it was not possible to calculate RR so we calculated the exact odds ratio instead. We used the GRADE tool to assess the quality of the body of evidence.
Twenty-one trials with 2570 participants met the inclusion criteria; 18 trials with 2376 participants for the prevention of dry socket and three studies with 194 participants for the treatment of dry socket. The risk of bias assessment identified six studies at high risk of bias, 14 studies at unclear risk of bias and one studies at low risk of bias. When compared to placebo, rinsing with chlorhexidine mouthrinses (0.12% and 0.2% concentrations) both before and after extraction(s) prevented approximately 42% of dry socket(s) with a RR of 0.58 (95% CI 0.43 to 0.78; P < 0.001) (four trials, 750 participants, moderate quality of evidence). The prevalence of dry socket varied from 1% to 5% in routine dental extractions to upwards of 30% in surgically extracted third molars. The number of patients needed to be treated with (0.12% and 0.2%) chlorhexidine rinse to prevent one patient having dry socket (NNT) was 232 (95% CI 176 to 417), 47 (95% CI 35 to 84) and 8 (95% CI 6 to 14) for control prevalences of dry socket of 1%, 5% and 30% respectively.Compared to placebo, placing chlorhexidine gel (0.2%) after extractions prevented approximately 58% of dry socket(s) with a RR of 0.42 (95% CI 0.21 to 0.87; P = 0.02) (two trials, in 133 participants, moderate quality of evidence). The number of patients needed to be treated with chlorhexidine gel to prevent one patient having dry socket (NNT) was 173 (95% CI 127 to 770), 35 (95% CI 25 to 154) and 6 (95% CI 5 to 26) for control prevalences of dry socket of 1%, 5% and 30% respectively.A further 10 intrasocket interventions to prevent dry socket were each evaluated in single studies, and therefore there is insufficient evidence to determine their effects. Five interventions for the treatment of dry socket were evaluated in a total of three studies providing insufficient evidence to determine their effects.
AUTHORS' CONCLUSIONS: Most tooth extractions are undertaken by dentists for a variety of reasons, however, all but three studies included in the present review included participants undergoing extraction of third molars, most of which were undertaken by oral surgeons. There is some evidence that rinsing with chlorhexidine (0.12% and 0.2%) or placing chlorhexidine gel (0.2%) in the sockets of extracted teeth, provides a benefit in preventing dry socket. There was insufficient evidence to determine the effects of the other 10 preventative interventions each evaluated in single studies. There was insufficient evidence to determine the effects of any of the interventions to treat dry socket. The present review found some evidence for the association of minor adverse reactions with use of 0.12%, 0.2% and 2% chlorhexidine mouthrinses, though most studies were not designed to detect the presence of hypersensitivity reactions to mouthwash as part of the study protocol. No adverse events were reported in relation to the use of 0.2% chlorhexidine gel placed directly into a socket (though previous allergy to chlorhexidine was an exclusion criterion in these trials). In view of recent reports in the UK of two cases of serious adverse events associated with irrigation of dry socket with chlorhexidine mouthrinse, it is recommended that all members of the dental team prescribing chlorhexidine products are aware of the potential for both minor and serious adverse side effects.
牙槽骨炎(干槽症)是拔牙术后的一种并发症,更常见于涉及下颌磨牙的拔牙手术。它与术后2至3天出现的剧烈疼痛有关,拔牙窝可能部分或完全没有血凝块,部分患者可能会有口臭的主诉。它会导致术后复诊次数增加。
评估局部干预措施对拔牙后牙槽骨炎(干槽症)的预防和治疗效果。
检索了以下电子数据库:Cochrane口腔健康组试验注册库(截至2012年10月29日)、Cochrane对照试验中心注册库(CENTRAL)(《Cochrane图书馆》2012年第10期)、通过OVID检索的MEDLINE(1946年至2012年10月29日)以及通过OVID检索的EMBASE(1980年至2012年10月29日)。对语言或出版日期没有限制。我们还检索了文章的参考文献列表,并联系了专家和组织以确定是否有其他进一步的研究。
我们纳入了18岁以上成年人的随机对照试验,这些成年人正在拔除恒牙或拔牙后发生了干槽症。我们纳入了使用任何类型的局部干预措施预防或治疗干槽症的研究,并与不同的局部干预措施、安慰剂或不进行治疗进行比较。我们排除了报告全身性使用抗生素或使用手术技术治疗干槽症的研究,因为这些干预措施在其他Cochrane综述中进行了评估。
两位综述作者独立使用预先设计的表格对纳入研究进行偏倚风险评估和数据提取,重复进行。如有不良事件报告,在可获取时将其记录并汇总成表格。当这些信息不清楚时,我们联系试验作者获取更多细节。我们遵循Cochrane协作网的统计指南,将二分法结果报告为风险比(RR),并使用随机效应模型计算95%置信区间(CI)。对于一些数据稀少的双侧对照研究,无法计算RR,因此我们计算了确切的比值比。我们使用GRADE工具评估证据的质量。
21项试验共2570名参与者符合纳入标准;18项试验共2376名参与者用于预防干槽症,3项研究共194名参与者用于治疗干槽症。偏倚风险评估确定6项研究存在高偏倚风险,14项研究偏倚风险不明确,1项研究存在低偏倚风险。与安慰剂相比,拔牙前后使用洗必泰漱口水(浓度为0.12%和0.2%)冲洗可预防约42%的干槽症,RR为0.58(95%CI 0.43至0.78;P<0.001)(4项试验,750名参与者,证据质量中等)。在常规拔牙中,干槽症的发生率从1%到5%不等,在手术拔除的第三磨牙中发生率超过30%。对于干槽症对照发生率分别为1%、5%和30%的情况,使用(0.12%和0.2%)洗必泰冲洗预防1例干槽症所需治疗的患者数(NNT)分别为232(95%CI 176至417)、47(95%CI 35至84)和8(95%CI 6至14)。与安慰剂相比,拔牙后放置洗必泰凝胶(0.2%)可预防约58%的干槽症,RR为0.42(95%CI 0.2至0.87;P = 0.02)(2项试验,133名参与者,证据质量中等)。对于干槽症对照发生率分别为1%、5%和30%的情况,使用洗必泰凝胶预防1例干槽症所需治疗的患者数(NNT)分别为173(95%CI 127至770)、35(95%CI 25至154)和6(95%CI 5至26)。另外10种预防干槽症的牙槽内干预措施分别在单项研究中进行了评估,因此没有足够的证据确定其效果。共有3项研究评估了5种治疗干槽症的干预措施,没有足够的证据确定其效果。
大多数拔牙手术是由牙医出于各种原因进行的,然而,本综述纳入的研究中除3项外均包括拔除第三磨牙的参与者,其中大多数是由口腔外科医生进行的。有证据表明,使用洗必泰(0.12%和0.2%)冲洗或在拔牙窝内放置洗必泰凝胶(0.2%)在预防干槽症方面有好处。没有足够的证据确定在单项研究中评估的其他10种预防干预措施的效果。没有足够的证据确定任何治疗干槽症干预措施的效果。本综述发现有一些证据表明使用浓度为0.12%、0.2%和2%的洗必泰漱口水与轻微不良反应有关,尽管大多数研究并非作为研究方案的一部分专门设计来检测对口漱口水的过敏反应。没有报告与直接在拔牙窝内使用0.2%洗必泰凝胶相关的不良事件(尽管在这些试验中,既往对洗必泰过敏是排除标准)。鉴于英国最近有两例与使用洗必泰漱口水冲洗干槽症相关的严重不良事件报告,建议所有开具洗必泰产品的牙科团队成员了解轻微和严重不良副作用的可能性。